|
Staging
is the process of finding out how far a cancer has spread. The extent
of spread of laryngeal or hypopharyngeal cancer is the most important
factor in selecting treatment options and estimating the course of a
patient’s illness and their outlook for recovery and survival
(prognosis). A staging system is a way for members of the cancer care
team to summarize the extent of a cancer's spread.
If you have laryngeal or hypopharyngeal cancer, ask your
cancer care team to explain the staging of your cancer in a way that
you understand. Knowing all you can about staging lets you take a more
active role in making informed decisions about your treatment.
The American Joint Committee on Cancer
(AJCC) TNM System
The most common system used to describe the stages of cancers
is the American Joint Committee on Cancer (AJCC) TNM system.
- T
stands for tumor
(its size and how far it has spread within the larynx and hypopharynx
and to nearby organs).
- N
stands for spread to nearby lymph nodes
in the neck (lymph nodes are bean-sized collections of immune system
cells that help fight infections and cancers).
- M
is for metastasis
(spread to distant organs).
Using the TNM
staging system, information about the tumor, lymph nodes, and
metastasis is combined to assign a stage. This process is called stage
grouping. The stage is described in Roman numerals from I to IV.
Patients with lower stage cancers have a better outlook for a cure or
long-term survival.
The T stage of cancers of the larynx and hypopharynx depends
on how far it has spread to the surrounding tissues from its origin.
Spread may be evaluated by indirect examinations using mirrors, by
direct endoscopy using scopes, and, if your doctor can reach it, by
feeling the texture of the area.
The T stage of laryngeal cancer also depends upon the movement
of the vocal cords. The doctor will watch the vocal cords with an
endoscope or special mirrors while the patient makes certain sounds. If
the vocal cords move normally, the cancer likely has not affected
deeper tissues. Vocal cord fixation (lack of movement) suggests
involvement by cancer. Imaging studies such as CT or MRI scans may be
used to add more detailed information.
T staging of laryngeal and hypopharyngeal cancers describes
spread of the cancer precisely in relation to specific areas of the
larynx, hypopharynx, and the surrounding structures. Higher T stage
numbers indicate more spread within the larynx or hypopharynx and to
other nearby areas in the neck.
The features used to assign the T stage of laryngeal cancer
vary according to the area of the larynx involved -- supraglottis,
glottis, or subglottis. T staging for hypopharyngeal cancer differs
from T staging for cancer of the larynx.
You may want to talk to your doctor about the stage of your
cancer. It will be important that the doctor illustrate it using a
diagram of the larynx.
T stages common to all laryngeal and
hypopharyngeal cancers
TX: not enough
information available to stage the tumor
T0: No tumor can be
found
Tis: Carcinoma in
situ. The cancer cells are only growing in the most superficial layer
(the epithelium), with no cancer growing into the underlying connective
tissue of the larynx or hypopharynx. (Very few hypopharyngeal and
larynx cancers are found at this early stage.)
T stages of supraglottic cancer
For cancer of the supraglottis, the T stage is based on how
many different parts (or sites) of the larynx are involved and how far
outside the larynx the cancer has spread. The 5 subsites of the
supraglottic part of the larynx are:
- the false vocal cords (or ventricular bands)
- arytenoids
- suprahyoid epiglottis
- infrahyoid epiglottis
- aryepiglottic folds
Whether or not the vocal cords move normally is also
considered. When the vocal cords do not move normally it often means
that the cancer is growing into them. This is a more advanced T stage.
T1: The
vocal cords move normally and the tumor is only growing in 1 subsite of
the supraglottis.
T2:
The tumor is growing into at least 2 subsites of the supraglottis; the
vocal cords still move normally.
T3: Either:
1) The tumor is growing only
in the larynx and has caused the vocal cords to stop moving.
OR
2) The tumor is growing into
the postcricoid area, paraglottic space, or pre-epiglottic (in front of
the epiglottis) tissues.
OR
3) Both #1 and #2 are true.
T4a: The
tumor is growing through thyroid cartilage (firm tissue that separates
the thyroid gland from the front of the larynx) and/or is growing into
tissues beyond the larynx (such as the trachea, esophagus, tongue
muscles, or neck muscles).
T4b: The
tumor is growing into the tissue in front of the spine in the neck (the
prevertebral space), is growing around a carotid artery, or is growing
down into the front of the chest cavity. T4b tumors are not able to be
removed completely with surgery.
T stages of glottic cancer
T1: The
tumor is growing only in the vocal cord(s); the vocal cords move
normally.
T1a: The tumor is
only growing in 1 vocal cord.
T1b: The tumor is on
both vocal cords.
T2:
The tumor is growing into the supraglottis and/or subglottis, and/or
the vocal cords move only a little.
T3:
The tumor is growing only in the larynx and the vocal cords
don’t move and/or the tumor is growing into the paraglottic
space, and/or the tumor has started growing into the thyroid cartilage
(firm tissue that separates the thyroid gland from the front of the
larynx).
T4a:
The tumor has grown through the thyroid cartilage and/or is growing
into tissues beyond the larynx (such as the trachea, esophagus, tongue
muscles, or neck muscles).
T4b: The
tumor is growing into the tissue in front of the spine in the neck (the
prevertebral space), surrounds a carotid artery, or is growing down
into the front of the chest cavity. T4b tumors are not able to be
removed completely with surgery.
T stages of subglottic cancer
T1: The
tumor is only growing in the subglottis.
T2: The
tumor has grown from the subglottis to the vocal cords, with normal or
reduced vocal cord movement.
T3: The
tumor is l growing only in the larynx and the vocal cords
don’t move.
T4a:
The tumor is growing through the cricoid or thyroid cartilage and/or is
growing into tissues beyond the larynx (such as the trachea, esophagus,
tongue muscles, or neck muscles).
T4b:
The tumor is growing into the tissue in front of the spine in the neck
(the prevertebral space), surrounds a carotid artery, is growing down
into the front of the chest cavity. T4b tumors are not able to be
removed completely with surgery.
T stages of hypopharyngeal cancer
Spread of cancer within the hypopharynx is described according
to the size of the tumor and how many areas (subsites) of the
hypopharynx are involved by the cancer. The 3 subsites of the
hypopharynx are the:
- pharyngo-esophageal junction
- pyriform sinus
- posterior pharyngeal wall
T1: The
tumor is growing only in 1 subsite of the hypopharynx and it is smaller
than 2 centimeters (cm) (about 3/4 of an inch) across.
T2:
Either
The tumor in growing in 2 or
more subsites of the hypopharynx.
OR
The tumor is growing in 1
subsite plus an area nearby.
OR
The tumor is 2 to 4 cm in
size with normal movement of the vocal cords.
T3: Either:
The tumor is larger than 4
cm (about 1 1/2 inches) across.
OR
The tumor is affecting the
movement of vocal cords.
T4a:
The tumor is growing into the cricoid or thyroid cartilage, hyoid bone,
thyroid gland, esophagus, or the strap muscles in front of the larynx.
T4b:
The tumor is growing into the space in front of the spine in the neck,
is growing around a carotid artery, or is growing down into the front
of the chest cavity. T4b tumors are not able to be removed completely
with surgery.
N (regional lymph node) stages of laryngeal
and hypopharyngeal cancers
The N staging is the same for laryngeal and hypopharyngeal
cancers. The stages are as follows:
NX: The
lymph nodes cannot be assessed (information not available).
N0:
There is no evidence of spread to the lymph nodes.
N1: The
cancer has spread to a single lymph node on the same side of the neck
as the tumor is. The lymph node is not larger than 3 cm (about
1¼ inch) across.
N2
N2a: The cancer has
spread to a single lymph node on the same side of the neck as the tumor
is. The lymph node is between 3 cm and 6 cm across.
N2b: The cancer has
spread to 2 or more lymph nodes on the same side of the neck as the
tumor is. None of these lymph nodes is larger than 6 cm across.
N2c: The cancer has
spread to lymph nodes on both sides of neck or on the side opposite the
tumor. None of these lymph nodes is larger than 6 cm across.
N3: The
cancer has spread to at least 1 lymph node that is larger than 6 cm.
M (distant metastasis) stages of laryngeal
and hypopharyngeal cancers
The M staging for all head and neck cancers, including
laryngeal and hypopharyngeal cancers, is the same. The stages are as
follows:
MX:
Information not available. Unable to tell if the cancer has spread to
distant sites is present.
M0: The
cancer has not spread to distant sites.
M1: The
cancer has spread to distant sites.
Stage grouping
Once the T, N, and M stages have been assigned, this
information is combined to assign an overall stage for the cancer. This
process is called stage
grouping. Stage grouping rules are the same for all
cancers of the hypopharynx and the supraglottic, glottic, and
subglottic areas of the larynx.
| Stage 0: |
Tis, N0, M0 |
| Stage I: |
T1, N0, M0 |
| Stage II: |
T2, N0, M0 |
| Stage III: |
T3, N0, M0, OR
T1, 2 or 3, N1, M0 |
| Stage IVA: |
T4a, N0, 1 or 2, M0, OR
T1, 2 or 3, N2, M0 |
| Stage IVB: |
T4b, Any N, M0, OR
Any T, N3, M0 |
| Stage IVC: |
Any T, Any N, M1 |
Survival rates by stage
Below are listed the 5-year relative survival rates for
cancers from each of the sites. These are data from the National Cancer
Data Base, published in the AJCC staging manual (see the "References"
section). The 5-year survival rate refers to the percentage of patients
who live at least 5 years after their cancer is diagnosed. Keep in mind
that many of these patients live much longer than 5 years after
diagnosis, and 5-year rates are used to produce a standard way of
discussing outlook (prognosis). 5-year relative survival rates
assume that some people will die of other causes and compare the
observed survival with that expected for people without the cancer.
This is a more accurate way to describe the prognosis for patients with
a particular type and stage of cancer. Of course, 5-year rates are
based on patients diagnosed and treated more than 5 years ago. Recently
diagnosed patients with many types of cancer may have a more favorable
outlook because of improvements in treatment.
Unfortunately, a recent study found that the average survival
for patients cancer of the larynx has not improved during the past
couple of decades (from 1974-1997) and the prognosis for hypopharyngeal
cancer improved only slightly. Nonetheless, there has been some been
very recent progress in treating these cancers, and there is hope that
the outlook for patients diagnosed in the past few years will be
better.
Supraglottis
| Stage |
5-year
relative survival (percent) |
| I |
83% |
| II |
70% |
| III |
57% |
| IV |
43% |
Glottis
| Stage |
5-year
relative survival (percent) |
| I |
65% |
| II |
62% |
| III |
55% |
| IV |
37% |
Subglottis
(These numbers are less accurate because of the small number of
patients.)
| Stage |
5-year
relative survival (percent) |
| I |
54% |
| II |
68% |
| III |
53% |
| IV |
36% |
Hypopharynx
| Stage |
5-year
relative survival (percent) |
| I |
41% |
| II |
36% |
| III |
36% |
| IV |
20% |
If you have any questions about the stage of your cancer or
how it affects your treatment, do not hesitate to ask your doctor.
Last Medical Review: 05/07/2009 Last Revised: 05/07/2009
|